Aperiomics Offering the Public a Chance to Help with Lyme Disease
Wednesday, April 27, 2016
Aperiomics has launched a crowdfunding campaign to support an adaptation of their technology to develop a faster and more accurate test for Lyme Disease than any currently available. Existing tests for this disease have up to a 70% diagnostic failure rate, a major problem considering that there are over 300,000 cases of Lyme Disease in this country alone, with many patients suffering from chronic infection.
A Better Way to Test for Lyme Disease in Ticks from Endemic Areas launched on April 22 and allows anyone to participate by contributing to the fund; donations can be for any dollar amount. The site allows all donors to share in every step of the research process, getting updates on study design, project data, and even being able to ask questions of the scientists. The site also has links to information about Lyme Disease and bios of the scientific team.
To participate in the crowdfunding project, donors are urged to contribute directly at www.experiment.com/lymedisease and to check back periodically as lab notes keep participants posted on progress.
According to Aperiomics CEO Crystal Icenhour, PhD, “We’re excited about the potential of this crowdfunding campaign which can both raise the funding we need to move our research forward, as well as educate the public about Lyme Disease and how to address it. What we are striving for is a transformation in Lyme Disease testing, not just an incremental advancement.” Aperiomics is seeking $14,575 to pay for sample collection, sequencing, materials and data analysis. Working through Experiment.com, the company has 30 days to reach its goal; donors are not charged unless the goal is reached.